NVS

Q: What is the price of Novartis (NVS) today?

The price of Novartis (NVS) today is US$ 130,03, with a variation of 15.91% compared to the last year. The price of Novartis (NVS) started the year trading around US$ 0,00 and today it is at US$ 130,03. Follow the real-time price chart, the historical price of Novartis (NVS), and stock data from Ibovespa and international markets.

Q: When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of April, totaling US$ 3,87. The Dividend Yield for the last 12 months is 2,92%.

Q: Novartis (NVS) is it worth it?

Currently, Novartis (NVS) is priced at US$ 130,03, with a P/E of 17,78%, representing a deviation of 19,22% from its historical average P/E. In the last year, the stock showed a variation of 15.91% in its price and distributed US$ 3,87 in dividends, resulting in a Dividend Yield of 2,92%. The total shareholder return was 15,91%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Novartis (NVS)?

Investing in stocks of Novartis (NVS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Novartis (NVS) yield today?

The yield of Novartis (NVS) was 2,75% in the last month, 15,91% in the last year and 91,61% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 3,87 in dividends, um Dividend Yield de 2,92%.If you wanted to buy 100 stocks of Novartis (NVS) today, the total investment would be US$ 13.003,00, based on the current price of US$ 130,03.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 15.071,78In 5 years: US$ 24.915,05In 10 years: 29.347,77It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Novartis AG

Price

US$ 130,03

variation (12m)

15,91%

p/l

17,78

p/vp

6,13

DIVIDEND YIELD

2,92%

price NVS

BVMF

NVS

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of NVS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

2,75%

3 months

7,45%

1 year

15,91%

2 years

43,01%

5 years

91,61%

10 years

125,70%

real profitability

profitability minus inflation.

1 month

2,75%

3 months

7,05%

1 year

10,83%

2 years

30,53%

5 years

41,59%

10 years

35,13%

Indicators NVS

check out the fundamentals of Novartis shares

P/E

17,78

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

4,54

Sector: 1,95 Industry: 2,78

P/BV

6,13

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

2,92%

Sector: - Industry: -

ROA

13,90%

Sector: -26,82% Industry: -52,06%

ROE

34,49%

Sector: -29,98% Industry: -40,51%

ROIC

17,07%

Sector: -411,56% Industry: -412,66%

NET MARGIN

25,52%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

76,79%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

31,52%

Sector: -23,36% Industry: -26,70%

P/EBITDA

11,13

Sector: 0,02 Industry: -2,09

P/EBIT

14,43

Sector: -1,26 Industry: -2,90

P/ASSET

2,47

Sector: 1,27 Industry: 1,41

BVPS

21,59

Sector: 3,73 Industry: 1,64

EPS

7,45

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,40

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

2,71%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

13,12%

Sector: - Industry: -

FAIR PRICE OF Novartis ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 130,03

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-53,74%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

NVS indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%
CNC	17,57	0,70	3,96%	0,00%	US$ 19,12 B	0,59%

comparison of NVS with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History NVS

current DY: 2,92%

5-year average DY: 4,22%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	12/03/2025	25/04/2025	3,86950000
Dividends	08/03/2024	19/04/2024	3,77700000
Dividends	10/03/2023	20/03/2023	3,46900000
Dividends	09/03/2022	17/03/2022	3,32530000
Dividends	05/03/2021	15/03/2021	3,37800000
Dividends	04/03/2020	12/03/2020	3,04200000
Dividends	05/03/2019	13/03/2019	2,86500000
Dividends	07/03/2018	25/04/2018	2,97700000
Dividends	03/03/2017	20/04/2017	2,74600000
Dividends	26/02/2016	15/04/2016	2,76200000
Dividends	04/03/2015	20/04/2015	2,81700000
Dividends	03/03/2014	10/04/2014	2,71900000
Dividends	28/02/2013	05/04/2013	2,53000000
Dividends	29/02/2012	05/04/2012	2,46000000
Dividends	28/02/2011	08/04/2011	2,35300000
Dividends	04/03/2010	13/04/2010	1,98700000
Dividends	26/02/2009	06/04/2009	1,72000000
Dividends	28/02/2008	11/04/2008	1,47200000
Dividends	08/03/2007	10/04/2007	1,08100000
Dividends	02/03/2006	03/04/2006	0,89400000
Dividends	03/03/2005	06/04/2005	0,98570000
Dividends	26/02/2004	30/03/2004	0,80600000
Dividends	06/03/2003	07/04/2003	0,70000000
Dividends	25/03/2002	22/04/2002	0,52200000
Dividends	26/03/2001	20/04/2001	0,50200000

ABOUT THE COMPANY Novartis

Novartis AG

Average user rating I10

4.0 (66 people)

Estados Unidos

29 years

Foundation: 1996

1996

Year of debut on the stock exchange - 29 years

105.794

Employees

The Company Novartis AG (Estados Unidos), is listed on NYSE with a market value of $ 257,90 Billions, having a net worth of $ 42,05 Billions.

With a total of 105.794 employees, the company is listed in the sector of Health and categorized in industry of Main Medications.

In the last 12 months the Company had a revenue of $ 56,85 Billions, which generated a profit in the amount of $ 14,51 Billions.

As for its main indicators, the Company has a P/E ratio of 17,78, a P/BV ratio of 6,13 and in the last 12 months the dividend yield of NVS was at 2,92%.

The Company is traded internationally through the ticker NVS.

Market value

US$ 257,90 Billions

Net worth

US$ 42,05 Billions

US$ 42.054.000.000,00

Assets

US$ 104,40 Billions

US$ 104.395.000.000,00

Total Number of Shares

1,95 Billion

1.948.000.000

Average Daily Trading Volume

US$ 1,36 Million

US$ 1.363.094,00

Sector

Health

Industry

Main Medications

NVS

NVS revenue and profits

NVS results

DRAG THE FRAME TO SEE MORE DATA

NVS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of Novartis (NVS) today?

The price of Novartis (NVS) today is US$ 130,03, with a variation of 15.91% compared to the last year. The price of Novartis (NVS) started the year trading around US$ 0,00 and today it is at US$ 130,03. Follow the real-time price chart, the historical price of Novartis (NVS), and stock data from Ibovespa and international markets.

When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of April, totaling US$ 3,87. The Dividend Yield for the last 12 months is 2,92%.

Novartis (NVS) is it worth it?

Currently, Novartis (NVS) is priced at US$ 130,03, with a P/E of 17,78%, representing a deviation of 19,22% from its historical average P/E. In the last year, the stock showed a variation of 15.91% in its price and distributed US$ 3,87 in dividends, resulting in a Dividend Yield of 2,92%. The total shareholder return was 15,91%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Novartis (NVS)?

Investing in stocks of Novartis (NVS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Novartis (NVS) yield today?

The yield of Novartis (NVS) was 2,75% in the last month, 15,91% in the last year and 91,61% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 3,87 in dividends, um Dividend Yield de 2,92%.

If you wanted to buy 100 stocks of Novartis (NVS) today, the total investment would be US$ 13.003,00, based on the current price of US$ 130,03.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 15.071,78
In 5 years: US$ 24.915,05
In 10 years: 29.347,77

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NVS

Novartis AG

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of NVS

check out the fundamentals of Novartis shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 2,92%

5-year average DY: 4,22%

type

date with

payment date

value

ABOUT THE COMPANY Novartis

Novartis AG

Estados Unidos

29 years

1996

105.794

PROFIT X PRICE NVS

NVS results

NVS cash flow

evolution of assets - NVS

NVS balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions